tinnitus, Phase Out, oorsuizen
Conditions
Interventions
A subject will receive Phase Out treatment for thirty minutes three times a week for one week and placebo sound treatment on the same regime during another. One month interval is in between these two
Sponsors
Universitair Medisch Centrum Groningen
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects > 18 years; 2. Unilateral or bilateral tinnitus; 3. Predominant tone tinnitus by history; 4. Tinnitus for minimum of 3 months;
Exclusion criteria
Exclusion criteria: 1. Acoustic neurinoma; 2. Aortic/ outflow tract stenosis; 3. Pulsatile tinnitus; 4. Pregnancy; 5. Inability to correct use of test equipment: unable to cooperate during audiologic examination; 6. Known tinnitus etiology, which would demand other treatment; 7. Hearing loss greater than 60 decibel compared with standardized normal hearing on standard frequencies of a tone audiogram (250; 500; 1000; 2000; 4000 en 8000 hertz).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The major aim of this study is disappearance (report mark) of the tinnitus lasting many hours (time). | — |
Secondary
| Measure | Time frame |
|---|---|
| Besides the mojor aims, different questionnaires will be used to determine for which kind of tinnitus patients, this treatment is most effective (THI, TRQ, VE, HADS, SF-36, Eysenck, type D personality, SSQ and TCSQ). | — |
Contacts
Public ContactK.M. Heijneman
Universitair Medisch Centrum Groningen, afd. Keel-,Neus-, Oorheelkunde Postbox 30.001
Outcome results
None listed